224 related articles for article (PubMed ID: 27878564)
1. The role of B7 family costimulatory molecules and indoleamine 2,3-dioxygenase in primary Sjögren's syndrome and systemic sclerosis.
Legány N; Berta L; Kovács L; Balog A; Toldi G
Immunol Res; 2017 Jun; 65(3):622-629. PubMed ID: 27878564
[TBL] [Abstract][Full Text] [Related]
2. B7 costimulation and intracellular indoleamine-2,3-dioxygenase (IDO) expression in peripheral blood of healthy pregnant and non-pregnant women.
Grozdics E; Berta L; Bajnok A; Veres G; Ilisz I; Klivényi P; Rigó J; Vécsei L; Tulassay T; Toldi G
BMC Pregnancy Childbirth; 2014 Sep; 14():306. PubMed ID: 25189405
[TBL] [Abstract][Full Text] [Related]
3. B7 costimulation and intracellular indoleamine 2,3-dioxygenase expression in umbilical cord blood and adult peripheral blood.
Grozdics E; Berta L; Gyarmati B; Veres G; Zádori D; Szalárdy L; Vécsei L; Tulassay T; Toldi G
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1659-65. PubMed ID: 24930629
[TBL] [Abstract][Full Text] [Related]
4. B7 costimulation and intracellular indoleamine-2,3-dioxygenase expression in peripheral blood of healthy pregnant and pre-eclamptic women.
Toldi G; Vásárhelyi B; Biró E; Fügedi G; Rigó J; Molvarec A
Am J Reprod Immunol; 2013 Mar; 69(3):264-71. PubMed ID: 23289444
[TBL] [Abstract][Full Text] [Related]
5. Umbilical cord mesenchymal stem cells inhibit the differentiation of circulating T follicular helper cells in patients with primary Sjögren's syndrome through the secretion of indoleamine 2,3-dioxygenase.
Liu R; Su D; Zhou M; Feng X; Li X; Sun L
Rheumatology (Oxford); 2015 Feb; 54(2):332-42. PubMed ID: 25169988
[TBL] [Abstract][Full Text] [Related]
6. B7-H3 participates in human salivary gland epithelial cells apoptosis through NF-κB pathway in primary Sjögren's syndrome.
Li P; Yang Y; Jin Y; Zhao R; Dong C; Zheng W; Zhang T; Li J; Gu Z
J Transl Med; 2019 Aug; 17(1):268. PubMed ID: 31412888
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic and functional activation of alveolar macrophages, T lymphocytes and NK cells in patients with systemic sclerosis and primary Sjögren's syndrome.
Gudbjörnsson B; Hällgren R; Nettelbladt O; Gustafsson R; Mattsson A; af Geijerstam E; Tötterman TH
Ann Rheum Dis; 1994 Sep; 53(9):574-9. PubMed ID: 7979595
[TBL] [Abstract][Full Text] [Related]
8. B7-H4 deficiency in salivary gland of patients with primary Sjögren's syndrome impairs the regulatory effect on T cells.
Li X; Yu D; Yu N; Wang X; Li X; Harris DCH; Wang Y
Int J Rheum Dis; 2017 Apr; 20(4):474-480. PubMed ID: 28217953
[TBL] [Abstract][Full Text] [Related]
9. Association of Increased Treg Cell Levels With Elevated Indoleamine 2,3-Dioxygenase Activity and an Imbalanced Kynurenine Pathway in Interferon-Positive Primary Sjögren's Syndrome.
Maria NI; van Helden-Meeuwsen CG; Brkic Z; Paulissen SM; Steenwijk EC; Dalm VA; van Daele PL; Martin van Hagen P; Kroese FG; van Roon JA; Harkin A; Dik WA; Drexhage HA; Lubberts E; Versnel MA
Arthritis Rheumatol; 2016 Jul; 68(7):1688-99. PubMed ID: 26866723
[TBL] [Abstract][Full Text] [Related]
10. Influence of total glucosides of paeony on PD-1/PD-L1 expression in primary Sjögren's syndrome.
Chen Y; Wang Y; Xu L; Zhu W; Xu C; Xu M; Guo L; Hu W; Xu D; Jing R; Zhu Y; He J; Xu B
Int J Rheum Dis; 2019 Feb; 22(2):200-206. PubMed ID: 30338648
[TBL] [Abstract][Full Text] [Related]
11. Detection of circulating soluble CD28 in patients with systemic lupus erythematosus, primary Sjögren's syndrome and systemic sclerosis.
Hebbar M; Jeannin P; Magistrelli G; Hatron PY; Hachulla E; Devulder B; Bonnefoy JY; Delneste Y
Clin Exp Immunol; 2004 May; 136(2):388-92. PubMed ID: 15086406
[TBL] [Abstract][Full Text] [Related]
12. Human CD14+ CTLA-4+ regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinoma.
Han Y; Chen Z; Yang Y; Jiang Z; Gu Y; Liu Y; Lin C; Pan Z; Yu Y; Jiang M; Zhou W; Cao X
Hepatology; 2014 Feb; 59(2):567-79. PubMed ID: 23960017
[TBL] [Abstract][Full Text] [Related]
13. Expression of the costimulatory molecule BB-1 and its receptors in patients with scleroderma-polymyositis overlap syndrome.
Murata KY; Sugie K; Takamure M; Ueno S
J Neurol Sci; 2002 Dec; 205(1):65-70. PubMed ID: 12409186
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of costimulatory molecules (CD28-CTLA-4/B7) expression on chosen mononuclear cells in adolescents with Graves' disease during methimazole therapy].
Bossowski A; Stasiak-Barmuta A; Urban M; Rinderle C
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):93-101. PubMed ID: 15504312
[TBL] [Abstract][Full Text] [Related]
15. STAT-5 is activated constitutively in T cells, B cells and monocytes from patients with primary Sjögren's syndrome.
Pertovaara M; Silvennoinen O; Isomäki P
Clin Exp Immunol; 2015 Jul; 181(1):29-38. PubMed ID: 25736842
[TBL] [Abstract][Full Text] [Related]
16. Immunoregulatory molecules in patients with gestational diabetes mellitus.
Pendeloski KP; Mattar R; Torloni MR; Gomes CP; Alexandre SM; Daher S
Endocrine; 2015 Sep; 50(1):99-109. PubMed ID: 25754913
[TBL] [Abstract][Full Text] [Related]
17. CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren's syndrome.
Gottenberg JE; Lavie F; Abbed K; Gasnault J; Le Nevot E; Delfraissy JF; Taoufik Y; Mariette X
J Autoimmun; 2005 May; 24(3):235-42. PubMed ID: 15848046
[TBL] [Abstract][Full Text] [Related]
18. SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis.
Orabona C; Pallotta MT; Volpi C; Fallarino F; Vacca C; Bianchi R; Belladonna ML; Fioretti MC; Grohmann U; Puccetti P
Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20828-33. PubMed ID: 19088199
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms dependent on tryptophan catabolism regulate immune responses in primary Sjögren's syndrome.
Pertovaara M; Raitala A; Uusitalo H; Pukander J; Helin H; Oja SS; Hurme M
Clin Exp Immunol; 2005 Oct; 142(1):155-61. PubMed ID: 16178870
[TBL] [Abstract][Full Text] [Related]
20. Sjogren's syndrome is associated with and not secondary to systemic sclerosis.
Salliot C; Mouthon L; Ardizzone M; Sibilia J; Guillevin L; Gottenberg JE; Mariette X
Rheumatology (Oxford); 2007 Feb; 46(2):321-6. PubMed ID: 16877466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
